Skip to main content
. 2016 Jun 23;11(6):e0157631. doi: 10.1371/journal.pone.0157631

Table 4. Univariate and multivariate analysis (n = 43343) of probable dengue-related mortality.

Variables Alive n (%) Dengue-related death, n (%) Univariate analysis, OR (95% CI) p Multivariate analysis, OR (95% CI) p
Mean Age, years (SD) 30.0 (15.7) 41.8 (20.5) 1.04 (1.03–1.05) <0.001 1.04 (1.03–1.06) <0.001
Gender
Male 26042 (99.8) 42 (0.2) 1 1
Female 17209 (99.7) 50 (0.3) 1.80 (1.20–2.72) 0.005 1.53 (1.01–2.33) 0.047
Nationality
Malaysian 39574 (99.8) 87 (0.2) 1.62 (0.66–3.98)
Non Malaysian 3677 (99.9) 5 (0.1) 1 0.297
Race (n = 39658) 0.369
Malay 23433 (99.8) 50 (0.2) 1
Chinese 10021 (99.8) 24 (0.2) 1.12 (0.69–1.83) 0.642
Indian 4216 (99.9) 6 (0.1) 0.67 (0.29–1.56) 0.349
Indigenous people 1652 (99.6) 7 (0.4) 1.99 (0.90–4.39) 0.090
Others 249 (100.0) 0 (0.0) 0.00 (0.00) 0.995
Place of dwelling (n = 38080)
Urban 31990 (99.8) 68 (0.2) 1
Rural 6005 (99.7) 17 (0.3) 1.33 (0.78–2.27) 0.291
Month of onset 0.752
December 2012 486 (99.8) 1 (0.2) 1
January 2283 (99.8) 5 (0.2) 1.30 (0.38–4.51) 0.675
February 1751 (99.7) 5 (0.3) 0.68 (0.16–2.87) 0.605
March 2000 (99.9) 3 (0.1) 0.71 (0.17–2.96) 0.635
April 1938 (99.8) 3 (0.2) 0.82 (0.22–3.05) 0.766
May 2230 (99.8) 4 (0.2) 1.16 (0.37–3.67) 0.796
June 2747 (99.7) 7 (0.3) 0.65 (0.18–2.44) 0.528
July 2789 (99.9) 4 (0.1) 1.10 (0.36–3.38) 0.862
August 3309 (99.8) 8 (0.2) 1.71 (0.63–4.65) 0.291
September 4532 (99.6) 17 (0.4) 0.85 (0.30–2.41) 0.759
October 7095 (99.8) 12 (0.2) 0.77 (0.27–2.19) 0.628
November 7095 (99.8) 12 (0.2) 0.89 (0.31–2.57) 0.830
December 5639 (99.8) 11 (0.2) 0.94 (0.11–8.06) 0.955
Headache
YES 32489 (99.8) 63 (0.2) 0.69 (0.44–1.07) 0.688
NO 10402 (99.7) 29 (0.3) 1
Suborbital Pain
YES 1653 (99.9) 2 (0.1) 1
NO 41598 (99.8) 90 (0.2) 1.79 (0.44–7.27) 0.417
Body or Joint Ache
YES 37134 (99.8) 73 (0.2) 1 1
NO 6117 (99.7) 19 (0.3) 1.58 (0.95–2.62) 0.076 1.52 (0.90–2.58) 0.120
Nausea and/or vomiting
YES 14867 (99.7) 47 (0.3) 1.99 (1.32–3.00) 0.001 1.80 (1.17–2.77) 0.008
NO 28384 (99.8) 45 (0.2) 1 1
Rash
YES 6689 (99.8) 11 (0.2) 1
NO 36562 (99.8) 81 (0.2) 1.35 (0.72–2.53) 0.354
Abdominal symptoms
YES 12455 (99.8) 31 (0.2) 1.26 (0.82–1.93) 0.301
NO 30796 (99.8) 61 (0.2) 1
Bleeding
YES 856 (99.2) 7 (0.8) 4.08 (1.88–8.84) <0.001 3.01 (1.29–7.04) 0.011
NO 42395 (99.8) 85 (0.2) 1 1
Abdominal pain or tenderness
YES 801 (99.6) 3 (0.4) 1.79 (0.56–5.66) 0.324
NO 42450 (99.8) 89 (0.2) 1
Persistent vomiting
YES 62 (96.9) 2 (3.1) 15.48 (3.73–64.25) <0.001 0.41 (0.01–18.35) 0.648
NO 43189 (99.8) 90 (0.2) 1 1
Clinical fluid accumulation
YES 2 (100.0) 0 (0.0)
NO 43249 (99.8) 92 (0.2) 1.00
Lethargy and/or restlessness
YES 310 (98.1) 6 (1.9) 9.66 (4.19–22.28) <0.001 5.97 (2.26–15.78) <0.001
NO 42491 (99.8) 86 (0.2) 1 1
Liver enlargement 2cm
YES 5 (100.0) 0 (0.0)
NO 43246 (99.8) 92 (0.2) 0.999
Severe plasma leakage
YES 25 (92.6) 2 (7.4) 38.42 (8.97–164.63) <0.001 14.72 (1.54–140.67) 0.020
NO 43226 (99.8) 90 (0.2) 1 1
Shock
YES 1 (25.0) 3 (75.0) 1457.87 (150.21–14149.51) <0.001 1805.37 (125.44–25982.98) <0.001
NO 43250 (99.8) 89 (0.2) 1 1
Severe bleeding
YES 0 (0.0) 0 (0.0)
NO 43251 (99.8) 92 (0.2)
Organ failure
YES 1 (50.0) 1 (50.0) 475.28 (29.50–7656.58) <0.001 2.947 (0.00–9.74x1010) 0.923
NO 43250 (99.8) 91 (0.2) 1 1